TrkA usually displayed tumour suppressor roles in NB and was linked to more favourable prognoses, while its splicing variant, TrkAIII on the other hand, was linked to unfavourable prognoses, metastatic disease, and disease relapse [59]. This evidence concerns the gene NTRK1 and neoplasm.